Panel Upholds Pharma Class Suit Dismissal

, New York Law Journal


Shifting fraud theories helped sink an attempted securities class action appeal by former employees of the pharmaceutical company Covis.

This premium content is reserved for New York Law Journal subscribers.

Continue reading by getting started with a subscription.

Already a subscriber? Log in now

What's being said

Comments are not moderated. To report offensive comments, click here.

Preparing comment abuse report for Article #1202792761403

Thank you!

This article's comments will be reviewed.